UpdatesGeneral Updates

Jubilant Pharmova secured USFDA approval for commercial batch manufacturing on Line 3 at its Spokane, USA contract facility.

Jubilant Pharmova Limited logo
Jubilant Pharmova LimitedJUBLPHARMA · Filed with the exchange

This green light for the new isolator-based fill and finish line boosts capacity and operational readiness, signaling enhanced business potential.

Read the original filing(PDF)

No comments yet. Be the first.

More from Jubilant Pharmova Limited

All announcements